InspireMD Inc (NSPR)-医療機器分野:企業M&A・提携分析

◆英語タイトル:InspireMD Inc (NSPR) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011148
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InspireMD Inc (InspireMD), formerly Saguaro Resources Inc is a medical device company that develops and commercializes stent platform MGuard technology. The company’s products include carotid embolic prevention system, Mguard embolic prevention system and Mguard prime. Its MGuard is based on net that is wrapped with an expandable MicroNet. InspireMD uses MGuard technology, which develops products that are applied in interventional cardiology and other vascular procedures. The company’s MGuard prime include mesh sleeve wrapped around a cobalt-chromium stent. It utilizes its technology to make products and offers solutions for various disease conditions such as stenting, embolic showers, restenosis and late stent thrombosis. The company markets its products through a network of distributors in Israel and Germany. InspireMD is headquartered in Tel Aviv, Israel.

InspireMD Inc (NSPR) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
InspireMD Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
InspireMD Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
InspireMD Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
InspireMD Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
InspireMD Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
InspireMD Inc, Medical Equipment, Deal Details 11
Venture Financing 11
InspireMD Raises USD0.2 Million in Venture Financing 11
InspireMD Raises USD0.6 Million in Venture Financing 12
Partnerships 13
InspireMD Amends Licensing Agreement With Svelte Medical For MGuard Prime 13
InspireMD Partners with Penumbra 14
Equity Offering 15
InspireMD to Raise USD0.8 Million in Private Placement of Series D Preferred Shares 15
InspireMD Prices Public Offering of Shares and Warrants for USD7.5 Million 16
InspireMD Raises USD14.6 Million in Public Offering of Preferred Stock and Warrants 17
InspireMD Raises USD1.1 Million in Public Offering of Shares and Warrants 18
InspireMD Raises USD0.6 Million in Private Placement of Shares and Warrants 19
InspireMD Raises USD14 Million in Public Offering of Shares and Warrants 21
InspireMD Raises USD8 Million in Private Placement of Shares and Warrants 22
InspireMD Files Registration Statement For Public Offering Of Shares For Up To US$40 Million 24
InspireMD Announces Rights Offering Of Shares 25
InspireMD Completes Public Offering Of Shares For US$25 Million 26
InspireMD Completes Private Placement Of US$9 Million 28
Debt Offering 29
InspireMD Completes Private Placement Of Convertible Debentures Due 2014 For US$11 Million 29
InspireMD Inc – Key Competitors 30
InspireMD Inc – Key Employees 31
InspireMD Inc – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Financial Announcements 33
Aug 08, 2017: Inspire Reports Double Digit Sequential and Year-Over-Year Revenue Growth for the Second Quarter of 2017 33
Aug 08, 2017: InspireMD Reports Double Digit Sequential and Year-Over-Year Revenue Growth for the Second Quarter of 2017 35
Feb 16, 2017: InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016 37
Nov 14, 2016: InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2016 39
Aug 09, 2016: InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2016 41
May 10, 2016: InspireMD Reports Financial Results for the First Quarter Ended March 31, 2016 43
Mar 28, 2016: InspireMD Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015 45
Corporate Communications 47
Jun 02, 2017: InspireMD Announces Appointment of Paul Stuka as Chairman of the Board 47
Oct 26, 2016: InspireMD Announces Appointment of Medical Device Industry Veteran Agustin Gago as Chief Commercial Officer 48
Sep 07, 2016: InspireMD Appoints Thomas Kester to Board of Directors 49
Jan 22, 2016: InspireMD Aligns Operations and Leadership Team, Appoints Isaac Blech as Vice Chairman of the Board 50
Legal and Regulatory 51
Aug 22, 2017: InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency and Expectation to Regain Compliance 51
Jul 21, 2016: InspireMD Regains Compliance With NYSE MKT Listing Standards 52
Product News 53
Nov 28, 2016: InspireMD to Present at LD Micro Main Event on December 6 53
Appendix 54
Methodology 54
About GlobalData 54
Contact Us 54
Disclaimer 54

List of Tables
InspireMD Inc, Medical Equipment, Key Facts, 2016 2
InspireMD Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
InspireMD Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
InspireMD Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
InspireMD Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
InspireMD Inc, Deals By Market, 2011 to YTD 2017 9
InspireMD Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
InspireMD Raises USD0.2 Million in Venture Financing 11
InspireMD Raises USD0.6 Million in Venture Financing 12
InspireMD Amends Licensing Agreement With Svelte Medical For MGuard Prime 13
InspireMD Partners with Penumbra 14
InspireMD to Raise USD0.8 Million in Private Placement of Series D Preferred Shares 15
InspireMD Prices Public Offering of Shares and Warrants for USD7.5 Million 16
InspireMD Raises USD14.6 Million in Public Offering of Preferred Stock and Warrants 17
InspireMD Raises USD1.1 Million in Public Offering of Shares and Warrants 18
InspireMD Raises USD0.6 Million in Private Placement of Shares and Warrants 19
InspireMD Raises USD14 Million in Public Offering of Shares and Warrants 21
InspireMD Raises USD8 Million in Private Placement of Shares and Warrants 22
InspireMD Files Registration Statement For Public Offering Of Shares For Up To US$40 Million 24
InspireMD Announces Rights Offering Of Shares 25
InspireMD Completes Public Offering Of Shares For US$25 Million 26
InspireMD Completes Private Placement Of US$9 Million 28
InspireMD Completes Private Placement Of Convertible Debentures Due 2014 For US$11 Million 29
InspireMD Inc, Key Competitors 30
InspireMD Inc, Key Employees 31
InspireMD Inc, Other Locations 32
InspireMD Inc, Subsidiaries 32

★海外企業調査レポート[InspireMD Inc (NSPR)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SPR Coffee:企業の戦略・SWOT・財務情報
    SPR Coffee - Strategy, SWOT and Corporate Finance Report Summary SPR Coffee - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Ford Motor Company:企業の戦略・SWOT・財務情報
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • First Midwest Bancorp, Inc.:企業の戦略・SWOT・財務情報
    First Midwest Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Midwest Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • C’Bon Cosmetics Co Ltd:企業の戦略・SWOT・財務分析
    C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report Summary C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • International Zeolite Corp:企業の戦略・SWOT・財務分析
    International Zeolite Corp - Strategy, SWOT and Corporate Finance Report Summary International Zeolite Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Zimmer Biomet Holdings Inc (ZBH)-製薬・医療分野:企業M&A・提携分析
    Summary Zimmer Biomet Holdings Inc (Zimmer Biomet) is a medical device company with focus on musculoskeletal healthcare. It carries out the design, development, manufacture, and marketing of reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, cr …
  • China Foods Ltd:企業の戦略・SWOT・財務分析
    China Foods Ltd - Strategy, SWOT and Corporate Finance Report Summary China Foods Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Genentech, Inc.:戦略・SWOT・企業財務分析
    Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Autolus Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Autolus Ltd (Autolus) is a biopharmaceutical company that develops anticancer therapies. The company uses T-cell programming and manufacturing technology to develop and commercialize T-cell therapies for cancer treatment. It uses chimeric antigen receptors (CARs) or T-cell receptors (TCRs) t …
  • Hempel AS:企業の戦略的SWOT分析
    Hempel AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • EA Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary EA Pharma Co Ltd (EA Pharma), formerly Ajinomoto Pharmaceuticals Co Ltd, a subsidiary of Eisai Co Ltd, is a clinical research organization that develops, manufactures and sells pharmaceutical products. The organization develops pharmaceutical products based on amino acid-related technologies …
  • Reach Subsea ASA (REACH):企業の財務・戦略的SWOT分析
    Reach Subsea ASA (REACH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Taubman Centers Inc (TCO):企業の財務・戦略的SWOT分析
    Taubman Centers Inc (TCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Crowley Maritime Corporation:石油・ガス:M&Aディール及び事業提携情報
    Summary Crowley Maritime Corp (Crowley Maritime) is a transportation and logistics company that offers marine solutions and services. Its service portfolio includes shipping and logistics, Alaska fuel sales and distribution, petroleum and chemical transportation, harbor ship assist and tanker escort …
  • Arotech Corporation:企業の戦略・SWOT・財務分析
    Arotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Arotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Eagle Pharmaceuticals Inc (EGRX):企業の財務・戦略的SWOT分析
    Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kratos Defense & Security Solutions, Inc.:企業の戦略・SWOT・財務情報
    Kratos Defense & Security Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kratos Defense & Security Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Parexel International Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆